Terminated EARLY_PHASE1 INTERVENTIONAL 1-arm NCT01846364

DIM as a Treatment for Thyroid Disease

Diindolymethane: Anti-proliferation Agent in Thyroid Disease-Non-surgical Protocol

Sponsor: The New York Eye & Ear Infirmary

Conditions Proliferative Thyroid Disease

Updated 6 times since 2017 Last updated: Apr 30, 2013 Started: Nov 30, 2006 Primary completion: Aug 31, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of sufficient enrollment

Other terminated trials from The New York Eye & Ear Infirmary

See all terminations from The New York Eye & Ear Infirmary

Listed as NCT01846364, this EARLY_PHASE1 trial focuses on Proliferative Thyroid Disease and remains terminated or withdrawn. Sponsored by The New York Eye & Ear Infirmary, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated EARLY_PHASE1
Sep 2020 — Jan 2021 [monthly]

Terminated EARLY_PHASE1
Feb 2017 — Sep 2020 [monthly]

Terminated EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated Phase 0

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The New York Eye & Ear Infirmary

Data source: The New York Eye & Ear Infirmary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States